How is the Inhibikase Therapeutics Inc today?

The Inhibikase Therapeutics Inc today is trading in the down by -3.38% at 2.00.

Inhibikase Therapeutics Inc XNAS: IKT

Inhibikase Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Inhibikase Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Inhibikase Therapeutics Inc
Rating: 1.26775
Author: Trendlyne DVM scores

Download real time

2.00 -0.07 (-3.38%)

52.38% Fall from 52W High

190.3K XNAS Volume

XNAS 14 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Inhibikase Therapeutics Inc is on 25 Apr 2025 for the purpose of Inhibikase Therapeutics Inc Annual Report for 2024 See details

Not Eligible

-

Expensive Valuation

8.0 / 100

Technically Neutral

42.7 / 100

No estimates available

Inhibikase Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Inhibikase Therapeutics Inc FAQ

How is Inhibikase Therapeutics Inc today?

Inhibikase Therapeutics Inc today is trading in the red, and is down by -3.38% at 2.00.

How has Inhibikase Therapeutics Inc performed historically?

Inhibikase Therapeutics Inc is currently trading down -3.38% on an intraday basis. In the past week the stock rose 8.70%. stock has been down -24.81% in the past quarter and fell -8.68% in the past year. You can view this in the overview section.